Recent Uploaded Publications
About
This database contains guidelines from the Genomics and Precision Health Database, sorted according to the highest evidence tier level that could be assigned to recommendations from each guideline. The sorting process is based on our previous method for classifying genomic applications (described in Clinical Pharmacology and Therapeutics, 2014), except that guideline documents rather than clinical scenarios are sorted according to evidence level. more
Recent Tier 1 Publications
Top 5 Most Viewed
|
Local Coverage Determination (LCD): Biomarker Testing for Neuroendocrine Tumors/Neoplasms (L37851)
The U.S. Centers for Medicare & Medicaid Services (201 reads) |
|
Cancer predisposition risk assessment system (K182784)
The U.S. Food & Drug Administration (189 reads) |
|
Draft Recommendation Statement and Draft Evidence Review: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer
The U.S. Preventive Services Task Force (175 reads) |
|
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia Sarah S et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Nov (169 reads) |
|
Cancer-related germline gene mutation detection system (P140020)
The U.S. Food & Drug Administration (166 reads) |